Bolt Biotherapeutics's total assets for Q2 2025 were $75.50M, a decrease of -12.07% from the previous quarter. BOLT total liabilities were $36.66M for the fiscal quarter, a -6.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.